Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients

被引:23
作者
Franceschini, Nora
Napravnik, Sonia
Finn, William F.
Szczech, Lynda A.
Eron, Joseph J., Jr.
机构
[1] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA
[3] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Div Nephrol & Hypertens, Chapel Hill, NC USA
[5] Duke Univ, Div Nephrol, Durham, NC USA
关键词
HIV; epidemiology; incidence; risk factors; acute renal failure; hepatitis C;
D O I
10.1097/01.qai.0000220165.79736.d3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Low CD4 cell Counts predict HIV-related morbidity and mortality and may be associated with acute renal failure (ARF). Objective: To estimate the effect of CD4 cell count on the incidence rate (IR) of ARF in ambulatory HIV-infected patients with access to highly active antiretroviral therapy. Methods: Observational clinical cohort of HIV-infected patients recruited from a university-based infectious diseases clinic, between 2000 and 2002, and followed up until December 31, 2002. Poisson log-linear regression models were used to calculate ARF IRs, IR differences, and IR ratios. Results: The mean age of the 705 study participants was 40 years, two thirds were male, and 61% were African American. Incidence rates of ARF were higher at lower CD4 cell counts and among patients who were coinfected with hepatitis C. Patients with hepatitis C coinfection who also had low CD4 cell counts had the highest adjusted IR of ARF. Conclusion: Immunosuppression and hepatitis C virus coinfection are associated with increased IRs of ARF in ambulatory HIV-1-infected patients.
引用
收藏
页码:368 / 372
页数:5
相关论文
共 22 条
[11]   Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:: A retrospective multicenter study [J].
Moreau, R ;
Durand, F ;
Poynard, T ;
Duhamel, C ;
Cervoni, JP ;
Ichaï, P ;
Abergel, A ;
Halimi, C ;
Pauwels, M ;
Bronowicki, JP ;
Giostra, E ;
Fleurot, C ;
Gurnot, D ;
Nouel, O ;
Renard, P ;
Rivoal, M ;
Blanc, P ;
Coumaros, D ;
Ducloux, S ;
Levy, S ;
Pariente, A ;
Perarnau, JM ;
Roche, J ;
Scribe-Outtas, M ;
Valla, D ;
Bernard, B ;
Samuel, D ;
Butel, J ;
Hadengue, A ;
Platek, A ;
Lebrec, D ;
Cadranel, JF .
GASTROENTEROLOGY, 2002, 122 (04) :923-930
[12]   HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia [J].
Napravnik, S ;
Edwards, D ;
Stewart, P ;
Stalzer, B ;
Matteson, E ;
Eron, JJ .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) :34-40
[13]   Hospital-acquired renal insufficiency [J].
Nash, K ;
Hafeez, A ;
Hou, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :930-936
[14]  
Olsen CH, 2005, AIDS, V19, P319
[15]  
RAO TKS, 1995, AM J KIDNEY DIS, V25, P390
[16]   THE TYPES OF RENAL-DISEASE IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
RAO, TKS ;
FRIEDMAN, EA ;
NICASTRI, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (17) :1062-1068
[17]   Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy [J].
Rockstroh, JK ;
Mocroft, A ;
Soriano, V ;
Tural, C ;
Losso, MH ;
Horban, A ;
Kirk, O ;
Phillips, A ;
Ledergerber, B ;
Lundgren, J .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) :992-1002
[18]   Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study [J].
Sterne, JAC ;
Hernán, MA ;
Ledergerber, B ;
Tilling, K ;
Weber, R ;
Sendi, P ;
Rickenbach, M ;
Robins, JM ;
Egger, M .
LANCET, 2005, 366 (9483) :378-384
[19]   Hepatitis C and progression of HIV disease [J].
Sulkowski, MS ;
Moore, RD ;
Mehta, SH ;
Chaisson, RE ;
Thomas, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02) :199-206
[20]  
*US PUBL HLTH SERV, 2005, GUID USE ANT AG HIV